Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2024 as against Rs 7.48 crore during the previous quarter ended June 2023. Sales rose 2.14% to Rs 61.44 crore in the quarter ended June 2024 as against Rs 60.15 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 61.44 | 60.15 | 2 |
| OPM % | 16.68 | 14.35 | - |
| PBDT | 11.47 | 10.48 | 9 |
| PBT | 10.40 | 10.09 | 3 |
| NP | 5.33 | 7.48 | -29 |